K

Kiniksa Pharmaceuticals

Biotechnology Research · United States · 500 employees

96 Decision makers
+14 New (6 months)
500 Employees
$841M Revenue
2015 Founded

Organizational Chart of Kiniksa Pharmaceuticals

Roles identified within Kiniksa Pharmaceuticals's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Kiniksa Pharmaceuticals's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Kiniksa Pharmaceuticals by function

General management

Finance

Human resources

Other functions

See all Kiniksa Pharmaceuticals contacts on Zeliq

Decision makers at Kiniksa Pharmaceuticals

96 identified 4 C-Level 14 VP 78 Directors +14 new (6 months)
See them on Zeliq →

Departments actively hiring 5 departments

General management
Marketing
Medical
Project management
Sales

These departments at Kiniksa Pharmaceuticals are actively recruiting: a strong signal to time your outreach.

Funding and news at Kiniksa Pharmaceuticals

Funding

Last round Other · $595K
Total funding $401M (5 rounds)
Series A $80M Oct 2015
Series B $40M Mar 2017
Series C $200M Feb 2018
Post-IPO Equity $80M May 2020
Post-IPO Equity $595K Sep 2025

Latest news at Kiniksa Pharmaceuticals

  1. Appointment

    New Regional Sales Director appointed — Sales

  2. Appointment

    New Regional Sales Director appointed — Sales

  3. Appointment

    New Sales Director appointed — Sales

  4. Appointment

    New Regional Sales Director appointed — Sales

  5. Appointment

    New Head of Talent Acquisition appointed — Human resources

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Sales
134
Hiring Medical
44
Other
39
Hiring General Management
27
Operations
27
Research
21
Finance
18
Hiring Project Management
11

How to prospect Kiniksa Pharmaceuticals's departments

Sales

First department of the company by headcount (134 people), with hiring underway. These profiles handle outreach daily and respond well to concrete pitches about pipeline, productivity and prospecting tooling.

Medical

Hiring is underway in this team of 44 people. Regulatory constraints and protocols shape everything here: show you understand their compliance context before pitching.

Other

A team of 39 people. Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

General Management

A team of 27 people, currently hiring. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

Project Management

This 11-person department is actively recruiting. These profiles own delivery: anything that de-risks a milestone gets their attention.

Marketing

Hiring is underway in this team of 9 people. Lead quality, data enrichment and sales alignment are recurring pains worth addressing in your opener.

Try the Zeliq email finder demo →

FAQ Kiniksa Pharmaceuticals

Who runs Kiniksa Pharmaceuticals?

The highest-ranking leadership role identified at Kiniksa Pharmaceuticals is “CFO”, based on public data updated 25 Oct 2026.

How many decision makers does Kiniksa Pharmaceuticals have?

96 decision makers identified, including 4 at executive level.

How do I contact a decision maker at Kiniksa Pharmaceuticals?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Kiniksa Pharmaceuticals?

General management, Marketing and Medical, based on published job offers as of 25 Oct 2026.

Companies similar to Kiniksa Pharmaceuticals

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals operates in the Biotechnology Research industry, operating from United States. Established in 2015, it employs approximately 500 people. As part of the broader Professional Services sector, Kiniksa Pharmaceuticals operates specifically in the Biotechnology Research segment. Kiniksa Pharmaceuticals is a B2B company, primarily serving business clients and professional organisations. The company has secured 5 rounds of funding totalling $401M. Its estimated yearly revenue stands at about $841M. Sales teams can rely on this profile to qualify Kiniksa Pharmaceuticals, spot business signals, and connect with verified decision makers.

Activity & Market

The company evolves in the Biotechnology Research segment of the Professional Services sector. As a B2B company, Kiniksa Pharmaceuticals primarily serves business clients and professional organisations. In terms of structure, it is registered as “Public company”.